Intracellular TDP-43 amyloid nucleates from arrested nascent condensates
Preprint
Abstract
Summary: TDP-43 is a model protein for pathophysiological phase transitions, forming a multitude of intracellular assemblies with different physical properties. Physiological condensation is widely presumed to precede pathological aggregation, but the causal relationships between different modes of assembly in vivo are still unclear. Here we use Distributed Amphifluoric FRET (DAmFRET) and complementary approaches to map the phase space of TDP-43 self-assembly in yeast cells. We discovered that the low-complexity C-terminal domain (CTD) on its own partitions into soluble clusters that dynamically arrest en route to liquid-liquid phase separation. These clusters uniquely supported amyloid formation, and only when templated by pre-existing amyloids of other proteins. Self-interacting modules outside the CTD, whether in the full-length TDP-43, pathological C-terminal fragments, or fusion partners, all suppressed amyloid nucleation. They did this by promoting CTD condensation beyond the arrested state. Stress and cotranslational self-association had the same effect. We leveraged this property of condensation to stop CTD amyloid formation by co-expressing an oligomeric binder in cells. Our findings reveal that TDP-43 amyloid formation occurs only under very specific physical and biological circumstances that present new opportunities for therapeutic control.Keywords
Funding Information
- National Institute of General Medical Sciences of the National Institutes of Health (R01GM130927)
- NIH and AlzheimerM-BM-^Rs Disease Center at the University of Kansas Medical Center (P30 AG035982)
- Woodyard Fellowship from the Institute for Neurological Discoveries at KUMC
- Stowers Institute for Medical Research
This publication has 129 references indexed in Scilit:
- A tool to dissect heterotypic determinants of homotypic protein phase behaviorProtein Science, 2025
- RNA aptamer reveals nuclear TDP-43 pathology is an early aggregation event that coincides with STMN-2 cryptic splicing and precedes clinical manifestation in ALSActa Neuropathologica, 2024
- Loss of TDP-43 splicing repression occurs early in the aging population and is associated with Alzheimer’s disease neuropathologic changes and cognitive declineActa Neuropathologica, 2023
- Truncated TDP‐43 proteoforms diagnostic of frontotemporal dementia with TDP‐43 pathologyAlzheimer's & Dementia, 2023
- Different Chronic Stress Paradigms Converge on Endogenous TDP43 Cleavage and AggregationMolecular Neurobiology, 2023
- Multistep Changes in Amyloid Structure Induced by Cross-Seeding on a Rugged Energy LandscapeBiophysical Journal, 2021
- Characterization of TDP-43 RRM2 Partially Folded States and Their Significance to ALS PathogenesisBiophysical Journal, 2018
- The physical forces mediating self-association and phase-separation in the C-terminal domain of TDP-43Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2018
- Structural Rearrangement upon Fragmentation of the Stability Core of the ALS-Linked Protein TDP-43Biophysical Journal, 2017
- ALS-causing cleavages of TDP-43 abolish its RRM2 structure and unlock CTD for enhanced aggregation and toxicityBiochemical and Biophysical Research Communications, 2017